Heart failure & cardiomyopathies

Ventricular Remodeling and Outcomes After Mitral Transcatheter Edge-to-Edge Repair in Heart Failure: The COAPT Trial

JACC Cardiovasc IntervPublished Secondary analysis of the COAPT randomised trial

Primary result · CV death, per 10 mL/m² decrease in LV end-diastolic volume index at 6 monthsResult — go to the resultAdjusted hazard ratio 0.90 95% CI 0.81–1.00

Authors' conclusion

In patients with HF and severe MR, LV reverse remodeling at 6 months was associated with subsequently improved 2-year outcomes but was not affected by TEER or the extent of residual MR.

Study context

Population
Patients with heart failure (HF) and severe mitral regurgitation (MR) symptomatic on guideline-directed medical therapy (GDMT)analytical cohort
Participants
348 patients
Comparison
Transcatheter edge-to-edge repair (TEER) vs GDMT alone
  • TEERn = 190
  • GDMT alonen = 158reference
Primary endpoint
Association of change in LV volumes (baseline to 6 months) with clinical outcomes from 6 months to 2 years
Follow-up
6 months to 2 years
Methodological detailscore laboratory, multivariable regression
  • Core laboratory
  • Multivariable regression

Primary result

As reported in the abstract

CV death, per 10 mL/m² decrease in LV end-diastolic volume index at 6 months

Adjusted hazard ratio

0.90

95% CI 0.81–1.00

P = 0.04

Decrease in LV end-diastolic volume index
adjusted HR 0.90 (95% CI 0.81–1.00); P = 0.04

Per 10 mL/m² decrease, as printed

Further findings

All-cause death, HF hospitalization; Left ventricular (LV) end-systolic volume index and all outcomes

Directionally similar but nonsignificant relationships

LV remodeling at 6 or 12 months by treatment group or 30-day MR severity

Neither treatment group nor MR severity at 30 days associated with LV remodeling

Treatment benefit of TEER by degree of LV remodeling at 6 months

TEER benefits not significant regardless of degree of LV remodeling

Original publication

Ventricular Remodeling and Outcomes After Mitral Transcatheter Edge-to-Edge Repair in Heart Failure: The COAPT Trial. JACC Cardiovasc Interv. Published 22 May 2023. doi:10.1016/j.jcin.2023.02.031

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.